Paula M Meek1, Robert Banzett2, Mark B Parsall3, Richard H Gracely4, Richard M Schwartzstein2, Robert Lansing5. 1. College of Nursing, University of Colorado - Denver, Aurora, CO. Electronic address: Paula.meek@ucdenver.edu. 2. Division of Pulmonary, Critical Care, and Sleep Medicine, Boston, MA; Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA. 3. College of Nursing, University of New Mexico, Albuquerque, NM. 4. Center for Neurosensory Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC. 5. Division of Pulmonary, Critical Care, and Sleep Medicine, Boston, MA.
Abstract
BACKGROUND: Most measures of dyspnea assess a single aspect (intensity or distress) of the symptom. We developed the Multidimensional Dyspnea Profile (MDP) to measure qualities and intensities of the sensory dimension and components of the affective dimension. The MDP is not indexed to a particular activity and can be applied at rest, during exertion, or during clinical care. We report on the development and testing of the MDP in patients with a variety of acute and chronic cardiopulmonary conditions. METHODS: One hundred fifty-one adults admitted to the ED with breathing symptoms completed the MDP three times in the ED, twice at least 1 h apart (T1, T2), and near discharge from the ED (T3). Measures were repeated in 68 patients twice in a follow-up session 4 to 6 weeks later (T4-T5). The ED sample was 56% men with a mean age of 53 ± 15 years; the follow-up sample was similar. RESULTS: Factor analysis resulted in a two-factor solution with a total explained variance of 63%, 74%, and 72% at T1, T2, and T3, respectively. One domain related to primary sensory qualities and immediate unpleasantness, and the second encompassed emotional response. For the two domains, Cronbach α ranged from 0.82 to 0.95, and the intraclass correlation coefficient ranged from 0.91 to 0.98. Repeated-measures analysis was significant for change (T1, T3, T4), showing responsiveness to change in MDP domains with treatment (F([2,66]) = 19.67, P > .001). CONCLUSIONS: These analyses support the reliability, validity, and responsiveness to clinical change of the MDP with two domains in an acute care and follow-up setting.
BACKGROUND: Most measures of dyspnea assess a single aspect (intensity or distress) of the symptom. We developed the Multidimensional Dyspnea Profile (MDP) to measure qualities and intensities of the sensory dimension and components of the affective dimension. The MDP is not indexed to a particular activity and can be applied at rest, during exertion, or during clinical care. We report on the development and testing of the MDP in patients with a variety of acute and chronic cardiopulmonary conditions. METHODS: One hundred fifty-one adults admitted to the ED with breathing symptoms completed the MDP three times in the ED, twice at least 1 h apart (T1, T2), and near discharge from the ED (T3). Measures were repeated in 68 patients twice in a follow-up session 4 to 6 weeks later (T4-T5). The ED sample was 56% men with a mean age of 53 ± 15 years; the follow-up sample was similar. RESULTS: Factor analysis resulted in a two-factor solution with a total explained variance of 63%, 74%, and 72% at T1, T2, and T3, respectively. One domain related to primary sensory qualities and immediate unpleasantness, and the second encompassed emotional response. For the two domains, Cronbach α ranged from 0.82 to 0.95, and the intraclass correlation coefficient ranged from 0.91 to 0.98. Repeated-measures analysis was significant for change (T1, T3, T4), showing responsiveness to change in MDP domains with treatment (F([2,66]) = 19.67, P > .001). CONCLUSIONS: These analyses support the reliability, validity, and responsiveness to clinical change of the MDP with two domains in an acute care and follow-up setting.
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Peter S Pang; John G F Cleland; John R Teerlink; Sean P Collins; Christopher J Lindsell; George Sopko; W Frank Peacock; Gregg C Fonarow; Amer Z Aldeen; J Douglas Kirk; Alan B Storrow; Miguel Tavares; Alexandre Mebazaa; Edmond Roland; Barry M Massie; Alan S Maisel; Michel Komajda; Gerasimos Filippatos; Mihai Gheorghiade Journal: Eur Heart J Date: 2008-03-01 Impact factor: 29.983
Authors: Phillip M Boiselle; Gaetane Michaud; David H Roberts; Stephen H Loring; Hilary M Womble; Mary E Millett; Carl R O'Donnell Journal: Chest Date: 2012-12 Impact factor: 9.410
Authors: Janet Rodríguez-Torres; Laura López-López; Irene Cabrera-Martos; Gerald Valenza-Demet; Lawrence P Cahalin; Marie Carmen Valenza Journal: Support Care Cancer Date: 2019-04-03 Impact factor: 3.603
Authors: Jennifer P Stevens; Andrew R Sheridan; Heather B Bernstein; Kathy Baker; Robert W Lansing; Richard M Schwartzstein; Robert B Banzett Journal: Chest Date: 2019-05-22 Impact factor: 9.410
Authors: Lea Ann Matura; Jamison Fargo; Jason S Fritz; Kerri A Smith; Anjali Vaidya; Diane Pinder; Christine Archer-Chicko; Harold I Palevsky; Allan I Pack; Marilyn S Sommers; Steven M Kawut Journal: Heart Lung Date: 2016-11-22 Impact factor: 2.210
Authors: Rup K Sainju; Deidre N Dragon; Harold B Winnike; Marcus B Nashelsky; Mark A Granner; Brian K Gehlbach; George B Richerson Journal: Epilepsia Date: 2019-02-12 Impact factor: 5.864
Authors: Julia M Cory; Michele R Schaeffer; Sabrina S Wilkie; Andrew H Ramsook; Joseph H Puyat; Brandon Arbour; Robbi Basran; Michael Lam; Christian Les; Benjamin MacDonald; Dennis Jensen; Jordan A Guenette Journal: J Appl Physiol (1985) Date: 2015-09-03